Topiramate: review of safety in pregnancy

Medicines and Healthcare products Regulatory Agency – 20th June 2024

This report presents the review of safety data conducted by the MHRA in 2022/2023, the advice of the CHM and the implementation group in 2023 and 2024, and the steps that the MHRA are taking to implement the new safety measures.

Topiramate: review of safety in pregnancy

Leave a comment